1. Home
  2. SQNS vs TLSA Comparison

SQNS vs TLSA Comparison

Compare SQNS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$4.77

Market Cap

85.3M

Sector

Technology

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.53

Market Cap

182.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQNS
TLSA
Founded
2003
2013
Country
France
United Kingdom
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.3M
182.7M
IPO Year
2011
2000

Fundamental Metrics

Financial Performance
Metric
SQNS
TLSA
Price
$4.77
$1.53
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$21.33
N/A
AVG Volume (30 Days)
151.5K
453.8K
Earning Date
02-10-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,534,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$70.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.20
N/A
52 Week Low
$4.84
$0.63
52 Week High
$58.30
$2.60

Technical Indicators

Market Signals
Indicator
SQNS
TLSA
Relative Strength Index (RSI) 33.82 42.23
Support Level $4.84 $1.45
Resistance Level $5.23 $1.62
Average True Range (ATR) 0.41 0.16
MACD -0.10 -0.01
Stochastic Oscillator 0.90 44.23

Price Performance

Historical Comparison
SQNS
TLSA

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: